Capstan Therapeutics logo

Capstan Therapeutics Funding & Investors

San Diego, CA

Capstan Therapeutics is advancing precision in vivo cell engineering to develop therapeutics for a broad range of disease categories with unmet or underserved clinical need.

capstantx.com

Total Amount Raised: $340,000,000

Capstan Therapeutics Funding Rounds

  • Series B

    $175,000,000

    Series B Investors

    Ra Capital Management
    Forbion
    Alexandria Venture Investments
    OrbiMed Advisors
    Vida Ventures
    Novartis Venture Fund
    Pfizer Venture Investments
    Leaps by Bayer
    Perceptive Advisors
    Sofinnova
    Johnson & Johnson Innovation – JJDC
    Polaris Partners
    Eli Lilly and Company Foundation
    Mubadala Capital Ventures
    Bristol-Myers Squibb
  • Series A

    $102,000,000

    Series A Investors

    Pfizer Venture Investments
    Leaps by Bayer
    Novartis Venture Fund
    OrbiMed Advisors
    Eli Lilly and Company Foundation
    Bristol-Myers Squibb
    Vida Ventures
    Alexandria Venture Investments
    Ra Capital Management
    Polaris Partners
  • Seed

    $63,000,000

    Seed Investors

    Novartis Venture Fund
    OrbiMed Advisors
    Vida Ventures
    Ra Capital Management
Funding info provided by Diffbot.